Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Top 5 Small-cap Biotech Stocks of 2025

More Featured Articles and Inverviews

Press Releases

More Press Releases

At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer

Go Deeper

AI Powered

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch in 2025

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Interactive Chart

×